Responsiveness of rituximab in refractory cases of inflammatory myopathies

被引:0
|
作者
No, J. [1 ,2 ]
Park, Y. [1 ,2 ]
机构
[1] Pusan Natl Univ Hosp, Yangsan, South Korea
[2] Pusan Natl Univ, Yangsan Hosp, Yangsan, South Korea
关键词
D O I
10.1016/j.nmd.2023.07.125
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P327
引用
收藏
页码:S96 / S96
页数:1
相关论文
共 50 条
  • [41] The use of rituximab in idiopathic inflammatory myopathies: description of a monocentric cohort and review of the literature
    Barsotti, S.
    Cioffi, E.
    Tripoli, A.
    Tavoni, A.
    d'Ascanio, A.
    Mosca, M.
    Neri, R.
    REUMATISMO, 2018, 70 (02) : 78 - 84
  • [42] Responsiveness to low-dose rituximab in refractory generalized myasthenia gravis
    Jing, Sisi
    Song, Yang
    Song, Jie
    Pang, Song
    Quan, Chao
    Zhou, Lei
    Huang, Yuyuan
    Lu, Jiahong
    Xi, Jianying
    Zhao, Chongbo
    JOURNAL OF NEUROIMMUNOLOGY, 2017, 311 : 14 - 21
  • [43] Response to cyclophosphamide and rituximab therapy in idiopathic inflammatory myopathies: A single center experience
    Shahin, Amira A.
    Niazy, Marwa H.
    Haroon, Maysa M.
    EGYPTIAN RHEUMATOLOGIST, 2021, 43 (03): : 247 - 251
  • [44] Responsiveness of muscle testing and functions in a retrospective 51 inflammatory myopathies patient series
    Devilliers, H.
    Shewaro, N.
    Allenbach, Y.
    Rigolet, A.
    Benveniste, O.
    NEUROMUSCULAR DISORDERS, 2013, 23 (9-10) : 846 - 846
  • [45] Efficacy of Rituximab in Refractory Inflammatory Myopathies Associated with Anti-Synthetase Auto-Antibodies: An Open-Label, Phase II Trial
    Allenbach, Yves
    Guiguet, Marguerite
    Rigolet, Aude
    Marie, Isabelle
    Hachulla, Eric
    Drouot, Laurent
    Jouen, Fabienne
    Jacquot, Serge
    Mariampillai, Kuberaka
    Musset, Lucile
    Grenier, Philippe
    Devilliers, Herve
    Hij, Adrian
    Boyer, Olivier
    Herson, Serge
    Benveniste, Olivier
    PLOS ONE, 2015, 10 (11):
  • [46] ANAKINRA EFFECTS ON T CELLS IN PATIENTS WITH REFRACTORY IDIOPATHIC INFLAMMATORY MYOPATHIES
    Zong, Mei
    Malmstrom, Vivianne
    Lundberg, Ingrid E.
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70
  • [47] Efficacy of Rituximab for the Treatment of Refractory Inflammatory Myopathies Associated with Anti-Histidyl-tRNA Synthetase Antibodies (the FORCE Jo1 Study).
    Allenbach, Yves
    Rigolet, Aude
    Guiguet, Marguerite
    Marie, Isabelle
    Hachulla, Eric
    Farge, Dominique
    Mariampillai, Kuberaka
    Jacquot, Serge
    Jouen, Fabienne
    Boyer, Olivier
    Musset, Lucile
    Herson, Serge
    Benveniste, Olivier
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S94 - S94
  • [48] EVOLUTIONARY PROFILE OF AUTOIMMUNE INFLAMMATORY MYOPATHIES: STUDY OF 22 CASES
    Abdellaoui, S.
    Boukabous, A.
    Bengana, B.
    Lefkir-Tafiani, S.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S341 - S341
  • [49] Idiopathic Inflammatory Myopathies in Childhood: A Brief Review of 27 Cases
    Lorenzoni, Paulo Jose
    Scola, Rosana Herminia
    Kamoi Kay, Claudia Suemi
    Prevedello, Priscila Greboge
    Espindola, Gisele
    Werneck, Lineu Cesar
    PEDIATRIC NEUROLOGY, 2011, 45 (01) : 17 - 22
  • [50] Rituximab-induced hypogammaglobulinaemia in patients affected by idiopathic inflammatory myopathies: a multicentre study
    Conticini, E.
    d'Alessandro, M.
    Grazzini, S.
    Rizzo, C.
    Fornaro, M.
    Cameli, P.
    Bennett, D.
    Abbruzzese, A.
    Camarda, F.
    Lopalco, G.
    Bergantini, L.
    Falsetti, P.
    Bargagli, E.
    Iannone, F.
    Guggino, G.
    Chinoy, H.
    Cantarini, L.
    Frediani, B.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (02) : 285 - 290